Botulinum Toxin Type A (Dysport) for Spastic Equinovarus Deformity after Stroke

Completed

Phase N/A Results

Summary of Purpose

To assess effects of intramuscular injection of botulinum toxin type A on calf spasticity causing equinovarus deformity, and to evaluate its impact on walking using 3 dosage levels.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2003.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Ispen Ltd.

Trial Design

Double-blind, randomized, multicenter study comparing placebo or botulinum toxin 500, 1000 or 1500 U in 234 patients.

Contacts

  • Mayo Clinic Department of Neurology 200 First St. SW Rochester, MN 55905

    Pittock.Sean@mayo.edu